scholarly article | Q13442814 |
P2093 | author name string | Chao Sun | |
Rui-Hua Shi | |||
Hai-Yang Wang | |||
Shu-Ping Yang | |||
Zhi-Ping Yuan | |||
Fang-Yuan Xu | |||
Lian-Zhen Yu | |||
P2860 | cites work | The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 |
Circulating Th17, Th22, and Th1 cells are increased in psoriasis | Q24629315 | ||
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling | Q24647357 | ||
STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice | Q28235220 | ||
Involvement of the IL-22/REG Ialpha axis in ulcerative colitis | Q28270049 | ||
IL-22 increases the innate immunity of tissues | Q28276850 | ||
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
Development, cytokine profile and function of human interleukin 17-producing helper T cells | Q29617131 | ||
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens | Q29617432 | ||
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
Cutting edge: immune cells as sources and targets of the IL-10 family members? | Q34129701 | ||
Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis | Q34224709 | ||
IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis | Q34577866 | ||
STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers | Q34796500 | ||
IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues | Q35761673 | ||
Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis | Q36228893 | ||
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis | Q36303708 | ||
Cytokine mediators of Th17 function | Q37326640 | ||
IL-22 and inflammation: leukin' through a glass onion | Q37328260 | ||
Interleukin-23/Th17 pathways and inflammatory bowel disease | Q37404716 | ||
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease | Q37633430 | ||
Dual roles for immunity in gastrointestinal cancers | Q37774172 | ||
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease | Q38423061 | ||
Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease | Q39902875 | ||
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation | Q40560155 | ||
Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. | Q40560646 | ||
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing | Q41953828 | ||
Inflammation and cancer: IL-6 and STAT3 complete the link. | Q41957513 | ||
Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction | Q42847300 | ||
Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice | Q46637445 | ||
Up-regulation of signal transducer and activator of transcription-3 is associated with aggravation of ulcerative colitis. | Q54415549 | ||
Colonic epithelial upregulation of interleukin 22 (IL-22) in patients with ulcerative colitis | Q57735560 | ||
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease | Q79502841 | ||
The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells | Q80167444 | ||
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration | Q82829186 | ||
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 | Q84365414 | ||
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis | Q84932668 | ||
Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease | Q84984314 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ulcerative colitis | Q1477 |
carcinogenesis | Q1637543 | ||
P304 | page(s) | 2638-2649 | |
P577 | publication date | 2013-05-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis | |
P478 | volume | 19 |
Q34346345 | Association of the interleukin-22 genetic polymorphisms with ulcerative colitis |
Q38753752 | Biological and pathological activities of interleukin-22. |
Q64906273 | Dual roles of IL-18 in colitis through regulation of the function and quantity of goblet cells. |
Q46026239 | Environmental triggers in IBD: a review of progress and evidence. |
Q38966340 | IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling |
Q38366373 | Inflammatory and redox reactions in colorectal carcinogenesis. |
Q90675719 | Interleukin 23 and autoimmune diseases: current and possible future therapies |
Q47108861 | Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats |
Q104505069 | Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer |
Q34390271 | Recent advancement in understanding colitis-associated tumorigenesis |
Q26998940 | STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer |
Q45944049 | Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. |
Q38172801 | Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy? |
Q35375460 | Th22 cell accumulation is associated with colorectal cancer development |
Q37224613 | Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling |
Search more.